EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The CDK 12– BRCA 1 signaling axis mediates dinaciclib‐associated radiosensitivity through p53‐mediated cellular senescence

Natalia García Flores iD, Diego M Fernández-Aroca iD, Cristina Garnés-García, Andrés Domínguez-Calvo, Jaime Jiménez-Suárez, Sebastià Sabater, Pablo Fernández-Aroca iD, Ignacio Andrés, Francisco J Cimas, Guillermo de Cárcer iD, Borja Belandia iD, Ignacio Palmero und 3 weitere

Molecular Oncology · 2025

DOI: 10.1002/1878-0261.13773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Natalia García Flores und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Oncología Molecular, Unidad de Medicina Molecular, Instituto de Biomedicina, Universidad de Castilla-La Mancha, Albacete, Spain. Hauptthemen laut MEDLINE: Indolizines, Cellular Senescence, Pyridinium Compounds, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Castilla-La Mancha, Agencia Estatal de Investigación, Europena Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pan‐cyclin‐dependent‐kinase (CDK) inhibitors are a new class of targeted therapies that can act on multiple CDKs, with dinaciclib being one of the most promising compounds. Although used as a monotherapy, an interesting approach could be to combine it with radiotherapy. Here, we show that dinaciclib increases radiosensitivity in some experimental models of lung and colon cancer (A549 or HCT 116) but not in others (H1299 or HT‐29). Dinaciclib did not alter serine‐protein kinase ATM signalling or cell cycle profiling after ionising‐radiation exposure, which have been described for other CDK inhibitors. Interestingly, in terms of apoptosis, although the combination renders a clear increase, no potentiation of the ionising‐radiation‐induced apoptosis was observed. Mechanistically, inhibition of CDK12 by dinaciclib diminishes BRCA1 expression, which decreases homologous recombination (HR) and probably promotes the nonhomologous end joining repair process (NHEJ), which ultimately promotes the induction of ionising‐radiation‐associated cellular senescence in a TP53 ‐dependent manner, explaining the lack of effect observed in some experimental models. In conclusion, our report proposes a molecular mechanism, based on the signalling axis CDK12–BRCA1, involved in this newly identified therapeutic effect of dinaciclib, although other players implicated in HR should not be discarded. In addition, our data provide a rationale for more selective and personalised chemo/radiotherapy treatment according to the genetic background of the tumour.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndolizinesCellular SenescencePyridinium CompoundsTumor Suppressor Protein p53Signal TransductionCyclin-Dependent KinasesRadiation ToleranceBRCA1 ProteinBridged Bicyclo Compounds, HeterocyclicHumansCyclic N-OxidesCell Line, TumorApoptosis

Stichwörter der Autor:innen

BRCA1CDK12dinaciclibradiosensitivitysenescence

Substanzen

dinaciclibIndolizinesPyridinium CompoundsTumor Suppressor Protein p53Cyclin-Dependent KinasesCyclic N-OxidesBRCA1 ProteinBridged Bicyclo Compounds, HeterocyclicBRCA1 protein, human

Autor:innen und Institutionen

  • Laboratorio de Oncología Molecular, Unidad de Medicina Molecular, Instituto de Biomedicina, Universidad de Castilla-La Mancha, Albacete, Spain.
  • Unidad de Biomedicina de la UCLM, Unidad asociada al CSIC, Albacete, Spain.
  • Centre for Genomics and Child Health, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, UK.
  • Translational Cancer Research Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
  • Facultad de Biología, Universidad de Sevilla, Spain.
  • Centro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER, Universidad de Sevilla-CSIC-Universidad Pablo de Olavide, Spain.

ORCID-Profile: Natalia García Flores, Diego M Fernández-Aroca, Pablo Fernández-Aroca, Guillermo de Cárcer, Borja Belandia, Pablo Huertas, María José Ruiz-Hidalgo, Ricardo Sánchez-Prieto

Förderung

  • Universidad de Castilla-La Mancha
  • Agencia Estatal de Investigación
  • Europena Regional Development Fund
  • Regional Government of Madrid
  • Agencia de Investigación e Innovación, Junta de Comunidades de Castilla-La Mancha
  • European Social Fund Plus
  • European Union - Next Generation EU
  • Ministerio de Educación, Formación Profesional y Deportes

Zitieren

APA

Flores, N. G., Fernández-Aroca, D. M., Garnés-García, C., Domínguez-Calvo, A., Jiménez-Suárez, J., Sabater, S., Fernández-Aroca, P., Andrés, I., Cimas, F. J., de Cárcer, G., Belandia, B., Palmero, I., Huertas, P., Ruiz-Hidalgo, M. J., & Sánchez-Prieto, R. (2025). The CDK 12– BRCA 1 signaling axis mediates dinaciclib‐associated radiosensitivity through p53‐mediated cellular senescence. Molecular Oncology. https://doi.org/10.1002/1878-0261.13773

Vancouver

Flores NG, Fernández-Aroca DM, Garnés-García C, Domínguez-Calvo A, Jiménez-Suárez J, Sabater S, et al. The CDK 12– BRCA 1 signaling axis mediates dinaciclib‐associated radiosensitivity through p53‐mediated cellular senescence. Molecular Oncology. 2025. doi:10.1002/1878-0261.13773

BibTeX
@article{Flores2025,
  author = {Flores, Natalia García and Fernández-Aroca, Diego M and Garnés-García, Cristina and Domínguez-Calvo, Andrés and Jiménez-Suárez, Jaime and Sabater, Sebastià and Fernández-Aroca, Pablo and Andrés, Ignacio and Cimas, Francisco J and de Cárcer, Guillermo and Belandia, Borja and Palmero, Ignacio and Huertas, Pablo and Ruiz-Hidalgo, María José and Sánchez-Prieto, Ricardo},
  title = {The CDK 12– BRCA 1 signaling axis mediates dinaciclib‐associated radiosensitivity through p53‐mediated cellular senescence},
  journal = {Molecular Oncology},
  year = {2025},
  doi = {10.1002/1878-0261.13773}
}
Kostenlos starten →